Insider · CIK 0001738144

Dorling Janet

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001738144

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−55K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-02-12	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$4.63	+$27.8K	6,000
2024-02-12	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	55,000
2024-02-12	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$31.97	−$192K	0
2024-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,010
2024-01-10	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$23.86	−$143K	0
2024-01-10	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	61,000
2024-01-10	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$4.63	+$27.8K	6,000
2023-12-11	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	67,000
2023-12-11	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$4.63	+$27.8K	6,000
2023-12-11	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$20.07	−$120K	0
2023-11-10	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,000 sh	$4.63	+$32.4K	7,000
2023-11-10	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,000 sh	—	—	73,000
2023-11-10	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−7,000 sh	$15.24	−$107K	0
2023-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+67K sh	—	—	67,000
2021-04-05	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2019-08-05	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+341K sh	—	—	341,000
2019-02-21	Achaogen, Inc.S Sale	Chief Commercial Officer	SSale	−1,063 sh	$0.89	−$946.07	284,738
2019-02-05	Achaogen, Inc.S Sale	Chief Commercial Officer	SSale	−818 sh	$1.35	−$1,104.3	285,801
2019-01-18	Achaogen, Inc.A Award	Chief Commercial Officer	AAward	+188K sh	—	—	286,619
2018-10-31	Achaogen, Inc.A Award	Chief Commercial Officer	AAward	+75K sh	—	—	98,819
2018-09-11	Achaogen, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+80K sh	—	—	80,000
2018-06-26	Achaogen, Inc.Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+6,000 sh	—	—	6,000
2018-06-26	Achaogen, Inc.S Sale	Chief Commercial Officer	SSale	−450 sh	$9.59	−$4,315.5	23,819
2018-06-26	Achaogen, Inc.A Award	Chief Commercial Officer	AAward	+1,300 sh	—	—	24,269

Recent filings

Accepted (ET)
Mar 224
Dorling Janet0000950170-24-035461
SEC(opens sec.gov)
Feb 144
Dorling Janet0001062993-24-003202
SEC(opens sec.gov)
Jan 264
Dorling Janet0001062993-24-001421
SEC(opens sec.gov)
Jan 104
Dorling Janet0001062993-24-000776
SEC(opens sec.gov)
Dec 114
Dorling Janet0001062993-23-022367
SEC(opens sec.gov)
Nov 144
Dorling Janet0001062993-23-020834
SEC(opens sec.gov)
Jan 274
Dorling Janet0001062993-23-001500
SEC(opens sec.gov)
Jan 274
Dorling Janet0001062993-22-001695
SEC(opens sec.gov)
Apr 54
Dorling Janet0001333277-21-000035
SEC(opens sec.gov)

Companies

Address

C/O ACHAOGEN, INC. 1 TOWER PLACE #300

SOUTH SAN FRANCISCO, CA, 94080